Wahdan M H, Sérié C, Cerisier Y, Sallam S, Germanier R
J Infect Dis. 1982 Mar;145(3):292-5. doi: 10.1093/infdis/145.3.292.
A controlled field trial of Salmonella typhi strain Ty 21a oral vaccine against typhoid was carried out in Alexandria, Egypt, from March 1978 to March 1981. A total of 32,388 children was included in the study. The children were divided in two comparable groups, one given three doses of vaccine and the other three doses of placebo. Each dose of vaccine contained 1-8 X 10(9) live Ty 21a bacteria. The population was monitored, and each suspected case of typhoid was investigated bacteriologically and serologically. The effectiveness of the vaccine was assessed by analyzing the number of confirmed cases of typhoid fever in the two groups. The incidence of typhoid fever was 4.9 cases per 10,000 children per year in the control group and 0.2 cases per 10,000 children per year in the vaccine group. The results indicate that, in the dose schedule used, the Ty 21a mutant strain, which is stable and safe, is protective for a period of at least three years.
1978年3月至1981年3月,在埃及亚历山大进行了一项针对伤寒的伤寒杆菌Ty 21a口服疫苗的对照现场试验。共有32388名儿童参与了该研究。这些儿童被分成两个可比组,一组接种三剂疫苗,另一组接种三剂安慰剂。每剂疫苗含有1 - 8×10⁹个活的Ty 21a细菌。对人群进行了监测,每例疑似伤寒病例都进行了细菌学和血清学调查。通过分析两组中确诊的伤寒热病例数来评估疫苗的有效性。对照组中伤寒热的发病率为每年每10000名儿童中有4.9例,疫苗组为每年每10000名儿童中有0.2例。结果表明,在所使用的剂量方案中,稳定且安全的Ty 21a突变株至少在三年内具有保护作用。